New Transfection Systems Tackle Delivery Issues and Off-Target Effects Will RNAi-based therapeutics provide the next class of blockbuster drugs? If pharma’s acquisition spree of companies with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback